Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies-Reference-Cited by-同舟云学术

Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies

Published:2023-12 Issue:12 Volume:41 Page:2136-2153.e13
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Nicosia Luciano,Spencer Gary J.,Brooks Nigel,Amaral Fabio M.R.,Basma Naseer J.,Chadwick John A.,Revell Bradley,Wingelhofer Bettina,Maiques-Diaz Alba,Sinclair Oliver,Camera Francesco,Ciceri Filippo,Wiseman Daniel H.,Pegg Neil,West Will,Knurowski Tomasz,Frese Kris,Clegg Karen,Campbell Victoria L.,Cavet James,Copland Mhairi,Searle Emma,Somervaille Tim C.P.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300;Dyson;J. Biol. Chem.,2016

2. Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer;Attar;Cold Spring Harb. Perspect. Med.,2017

3. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome;Weinert;Cell,2018

4. Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation;Delvecchio;Nat. Struct. Mol. Biol.,2013

5. Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma;Meyer;Immunity,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer;Oncogene;2024-09-13

2. Pan-cancer analysis of Sp1 with a focus on immunological roles in gastric cancer;2024-08-09

3. Understanding the Cryptosporidium species and their challenges to animal health and livestock species for informed development of new, specific treatment strategies;Frontiers in Parasitology;2024-08-06

4. Comprehensive summary: the role of PBX1 in development and cancers;Frontiers in Cell and Developmental Biology;2024-07-26

5. Design, synthesis and biological evaluation of new RNF126-based p300/CBP degraders;Bioorganic Chemistry;2024-07